Chapters
Introduction
Introduction
0:00
Introduction
0:00
MS 1819
MS 1819
0:23
MS 1819
0:23
Option 2 Trial
Option 2 Trial
1:33
Option 2 Trial
1:33
Capsule Type
Capsule Type
2:16
Capsule Type
2:16
Expectations for readout
Expectations for readout
3:07
Market size
Market size
3:41
Market size
3:41
Chronic pancreatitis
Chronic pancreatitis
4:16
Chronic pancreatitis
4:16
Key differentiating factor
Key differentiating factor
8:19
When will the clinical trial start
When will the clinical trial start
9:05
How many trial sites
How many trial sites
9:52
How many trial sites
9:52
Emergency use authorization
Emergency use authorization
10:31
Overall vs rectal formulations
Overall vs rectal formulations
10:58
When do you plan to start a trial
When do you plan to start a trial
11:45
Are there any drugs on the market
Are there any drugs on the market
12:56
How does Azeroth X plan to commercialize
How does Azeroth X plan to commercialize
14:21
Does Azeroth X have sufficient capital
Does Azeroth X have sufficient capital
15:31
Will you consider bringing additional candidates or indications for the pipeline
Will you consider bringing additional candidates or indications for the pipeline
16:15
Closing remarks
Closing remarks
16:38
Closing remarks
16:38
Sync to video time
Description
6Likes
383Views
2021Mar 22
Chapters
View all
View all
Transcript
Follow along using the transcript.
Show transcript
Transcript
NaN / NaN